Literature DB >> 30872156

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Ali Alikhan1, Christopher Sayed2, Afsaneh Alavi3, Raed Alhusayen3, Alain Brassard4, Craig Burkhart5, Karen Crowell6, Daniel B Eisen4, Alice B Gottlieb7, Iltefat Hamzavi8, Paul G Hazen9, Tara Jaleel10, Alexa B Kimball11, Joslyn Kirby12, Michelle A Lowes13, Robert Micheletti14, Angela Miller8, Haley B Naik15, Dennis Orgill16, Yves Poulin17.   

Abstract

Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nd:YAG; acne inversa; adalimumab; biomarkers; carbon dioxide laser; clindamycin; comorbidities; ertapenem; finasteride; guidelines; hidradenitis suppurativa; infliximab; laser; lifestyle modification; microbiome; oral contraceptive pills; rifampin; spironolactone

Mesh:

Substances:

Year:  2019        PMID: 30872156      PMCID: PMC9131894          DOI: 10.1016/j.jaad.2019.02.067

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   15.487


  207 in total

1.  Surgical management of genitoperineal hidradenitis suppurativa in men.

Authors:  Mang L Chen; Brian Odom; Richard A Santucci
Journal:  Urology       Date:  2014-03-28       Impact factor: 2.649

2.  Treatment of hidradenitis suppurativa with etanercept injection.

Authors:  David R Adams; Jessica A Yankura; Anneli C Fogelberg; Bryan E Anderson
Journal:  Arch Dermatol       Date:  2010-05

3.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

4.  Successful treatment of widespread chronic gluteal hidradenitis suppurativa with combination of recycled skin graft and negative-pressure wound therapy.

Authors:  Misaki Kinoshita-Ise; Yoshio Nakamura; Yoshiko Kumagai; Akiharu Kubo; Keisuke Nagao; Takeru Funakoshi
Journal:  J Dermatol       Date:  2016-09-21       Impact factor: 4.005

5.  Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents.

Authors:  Hannu Tiri; Jari Jokelainen; Markku Timonen; Kaisa Tasanen; Laura Huilaja
Journal:  J Am Acad Dermatol       Date:  2018-03-05       Impact factor: 11.527

6.  Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.

Authors:  Alexa B Kimball; Murali Sundaram; Benjamin Banderas; Catherine Foley; Alan L Shields
Journal:  J Dermatolog Treat       Date:  2017-07-04       Impact factor: 3.359

7.  Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.

Authors:  K Wolk; J Wenzel; A Tsaousi; E Witte-Händel; N Babel; C Zelenak; H-D Volk; W Sterry; S Schneider-Burrus; R Sabat
Journal:  Br J Dermatol       Date:  2017-09-19       Impact factor: 9.302

8.  ALA-PDT and blue light therapy for hidradenitis suppurativa.

Authors:  Michael Gold; Tancy M Bridges; Virginia Lee Bradshaw; Molly Boring
Journal:  J Drugs Dermatol       Date:  2004 Jan-Feb       Impact factor: 2.114

Review 9.  The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review.

Authors:  Raphael Parrado; Manuel Cadena; Arturo Vergara; Diana Cadena; Juan G Chalela
Journal:  Int Wound J       Date:  2015-12-13       Impact factor: 3.315

10.  The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients.

Authors:  Christian Posch; Babak Monshi; Tamara Quint; Igor Vujic; Nikolaus Lilgenau; Klemens Rappersberger
Journal:  J Am Acad Dermatol       Date:  2017-04-01       Impact factor: 11.527

View more
  39 in total

1.  Hidradenitis Suppurativa or Hidradenitis Suppurativa-Like Lesions Located on Amputation Stumps? Description of 2 Cases.

Authors:  Nicolas Kluger; Philippe Guillem; Minttu Kivivuori; Kirsi Isoherranen
Journal:  Skin Appendage Disord       Date:  2019-10-10

2.  Comprehensive approach to managing hidradenitis suppurativa patients.

Authors:  Erin K Collier; Jennifer L Hsiao; Vivian Y Shi; Haley B Naik
Journal:  Int J Dermatol       Date:  2020-04-06       Impact factor: 2.736

Review 3.  Hormonal Contraceptives and Dermatology.

Authors:  Natalie M Williams; Michael Randolph; Ali Rajabi-Estarabadi; Jonette Keri; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

4.  Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa.

Authors:  Kyla N Price; Alyssa M Thompson; Omar Rizvi; Aleksi J Hendricks; Afsaneh Alavi; Jennifer L Hsiao; Vivian Y Shi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

5.  Diagnosis and management of hidradenitis suppurativa in women.

Authors:  Erin K Collier; Ram K Parvataneni; Michelle A Lowes; Haley B Naik; Martin Okun; Vivian Y Shi; Jennifer L Hsiao
Journal:  Am J Obstet Gynecol       Date:  2020-09-24       Impact factor: 8.661

6.  Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event.

Authors:  N Shukla; M Paul; M Halley; M A Lowes; V Hester; C Aguilar; S Guilbault; T S Long; A Taylor; A C Thompson; C A Yannuzzi; E Linos; H B Naik
Journal:  Br J Dermatol       Date:  2020-01-29       Impact factor: 9.302

Review 7.  Hidradenitis Suppurativa: Surgical and Postsurgical Management.

Authors:  Marco Manfredini; Federico Garbarino; Laura Bigi; Giovanni Pellacani; Cristina Magnoni
Journal:  Skin Appendage Disord       Date:  2020-05-14

8.  Assessment of familial risk in patients with hidradenitis suppurativa.

Authors:  R L Bruinsma; K Fajgenbaum; Y Yang; M Del Mar Melendez-Gonzalez; K L Mohlke; Y Li; C Sayed
Journal:  Br J Dermatol       Date:  2021-01-04       Impact factor: 9.302

9.  Hidradenitis suppurativa among patients with HIV: investigating patient and disease characteristics and misdiagnosis.

Authors:  H Bui; P N Skiba; A Breskin; C Sayed
Journal:  Br J Dermatol       Date:  2021-08-17       Impact factor: 9.302

10.  Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report.

Authors:  Pelin Esme; Gulsen Akoglu; Ercan Caliskan
Journal:  Skin Appendage Disord       Date:  2020-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.